Information for Readers

Aims and Scope

Hepatobiliary & Pancreatic Diseases International publishes peerreviewed original papers, reviews (meta-analysis, systematic review) and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases.Papers cover the medical, surgical, radiological, pathological,biochemical,physiological and histological aspects of the subject areas under the headings Liver,Biliary,Pancreas,Transplantation,Research, Editorials, Review Articles, New Techniques, Clinical Images, Viewpoints and Letters to the Editor. The journal also deals with the basic sciences and experimental work. All submitted papers are reviewed by at least two referees in the field of the submitted paper.For detailed instructions concerning the submission of manuscripts, please refer to the Instructions for Authors in each issue of the journal.Full articles are available at ScienceDirect.

Editorial Office

Hepatobiliary & Pancreatic Diseases International, the First Affiliated Hospital, Zhejiang University School of Medicine,79 Qingchun Road, Hangzhou 310003, China. Tel: +86-571-87236559,+86-571-87236600;Fax:+86-571-87236559;E-mail:hbpdint@126.com,hbpdje@zju.edu.cn.

Business Correspondence and Advertising Principles

All matters relating to orders, subscriptions, back issues,offprints, advertisement booking and general enquiries should be addressed to: Yan-Ping Dong; E-mail: hbpdint@126.com;visit our website at http://www.hbpdint.com. Advertisements in this journal have to be reviewed to comply with the principles governing advertising in this journal. The appearance of advertising in Hepatobiliary&Pancreatic Diseases International is not a guarantee or endorsement of the product or the claims made for the product.

Subscription Rates

The journal is published 6 times per year and the prices for 2023 are as follows:Institution:US$400(rest of world);Personal:US$200. The journal is despatched to subscribers outside China by surface air-lifted delivery.

Database

Hepatobiliary & Pancreatic Diseases International is abstracted and indexed in Chemical Abstracts (CA), EMBASE/Excerpta Medica (EM), Index Medicus (IM)/MEDLINE, Science Citation Index Expanded (SCI-E), SCOPUS. Electronic availability http://www.hbpdint.com. The impact factor of the journal is 3.3(Clarivate Analytics 2022 Journal Citation Reports).

Disclaimer

The publisher, the hospital and the editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal;the views and opinions expressed do not necessarily reflect those of the publisher,the hospital or the editors, neither does the publication of advertisements constitute any endorsement by the publisher,the hospital or the editors of the products advertised.

Copyright and Photocopying

© 2023 Hepatobiliary & Pancreatic Diseases International, the First Affiliated Hospital, Zhejiang University School of Medicine,Hangzhou 310003, China. All rights reserved. No part of this publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the owner of the journal.